Literature DB >> 2249722

Vaccination campaign against meningococcal disease in army recruits in Italy.

T Stroffolini1.   

Abstract

A high attack rate (17.3/100,000) of meningococcal disease in army recruits in Italy, with 95% of the cases due to serogroup C, constituted the motivating factors to make bivalent serogroup A + C meningococcal vaccination compulsory by law for army recruits starting January 1987. Because the vaccine was given only to the new recruits entering the army, full coverage was not achieved until January 1988. Nearly 900,000 subjects (300,000 yearly) were vaccinated between January 1987 and December 1989. There were no reports of any untoward reactions to the vaccine. Of the 300,000 recruits in service each year, 52, 21, 15, 5 and 4 cases of the disease occurred in 1985, 1986, 1987, 1988 and 1989, respectively (P less than 0.001). Of the 24 cases occurring since the start of the vaccination, only two (due to serogroup C) were attributable to vaccine failure. The remaining cases were in unvaccinated recruits (15 cases) or were due to serogroups other than A or C (7 cases). The cumulative incidence of meningococcal serogroup C in the 600,000 vaccinated recruits during the period 1988-89 was 0.2/100,000 (1 case amongst 600,000 recruits), while the corresponding figure in the 600,000 unvaccinated recruits during the period 1985-6 was 11.3/100,000 (68 cases amongst 600,000 recruits) (P less than 0.001). The protective efficacy of the vaccine in 1987 was 91.2% (12 cases of meningococcal serogroup A and C disease from an average of 150,000 unvaccinated recruits observed for 1 year, and 1 case from the corresponding average of 150,000 vaccinated ones). In 1988 and in 1989 this figure could not be calculated because all recruits were vaccinated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2249722      PMCID: PMC2271833          DOI: 10.1017/s0950268800048214

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  7 in total

1.  Trends in meningococcal disease in Italy in 1986.

Authors:  T Stroffolini; C M Curianó; M E Congiu; M Occhionero; P M Gianfrilli
Journal:  Public Health       Date:  1988-03       Impact factor: 2.427

2.  Dyslexia and monocular occlusion.

Authors:  C R Wilsher
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

3.  Group-specific meningococcal vaccination and epidemics caused by other groups of meningococci.

Authors:  P H Mäkelä; H Peltola
Journal:  Lancet       Date:  1978-10-07       Impact factor: 79.321

4.  Is group-specific meningococcal vaccination resulting in epidemics caused by groups of virulent meningococci?

Authors:  J Nikoskelainen; A Leino; E Lähtönen; J L Kalliomäki; A Toivanen
Journal:  Lancet       Date:  1978-08-19       Impact factor: 79.321

5.  Immunoprophylaxis of meningococcal infection.

Authors:  M S Artenstein; P E Winter; R Gold; C D Smith
Journal:  Mil Med       Date:  1974-02       Impact factor: 1.437

Review 6.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

7.  A one year survey of meningococcal disease in Italy.

Authors:  T Stroffolini; F Rosmini; C M Curianò
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

  7 in total
  6 in total

1.  Pattern of bacterial meningitis in Italy, 1994.

Authors:  S Salmaso; P Mastrantonio; G Scuderi; M E Congiu; T Stroffolini; M G Pompa; S Squarcione
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

2.  First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.

Authors:  R Almog; C Block; M Gdalevich; B Lev; M Wiener; S Ashkenazi
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

Review 3.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

Review 4.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

Review 5.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

6.  Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic.

Authors:  P Kriz; J Vlckova; M Bobak
Journal:  Epidemiol Infect       Date:  1995-12       Impact factor: 2.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.